MAPK1 and Alzheimer disease: Subsequently, signal transduction routes interference, involves PKC, cAMP–PKA, MAPK–ERK, and PI3K, in numerous neurotransmitter systems, and could provide an alternative measure for AD patient neuroprotection, memory, and cognitive enhancement.